We are reimagining medicine to power breakthrough innovation in cell and gene therapy
New cell and gene facility inaugurated in Switzerland
Novartis opens facility for innovative cell and gene therapies at our Stein manufacturing site in the canton of Aargau.
Delivering on the promise of cell and gene therapy for patients
New advances in cell and gene therapies offer the potential to transform medicine. They create an inflection point in our ability to treat and even potentially cure many intractable illnesses.
What is cell and gene therapy?
An introduction to cell and gene therapy.
A new era of medicine
Cell and gene therapies could help reduce or eliminate the need for treatments that need to be taken continuously, often for life.
Key focus areas
Currently, there are three key focus areas for development of transformative cell and gene therapies at Novartis: AAV-based therapies, CAR-T cell therapies and CRISPR-based technologies.
Hardwiring the future
A Cell & Gene production unit staffed by a highly trained team at Novartis will soon begin operating in Stein, Switzerland.
Learn more about the power of cell and gene therapies
Cell & Gene-related media releases